๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intravenous pyelography in a series of cases after transplantation of the ureters

โœ Scribed by G. Grey Turner; James H. Saint

Publisher
John Wiley and Sons
Year
1936
Tongue
English
Weight
942 KB
Volume
23
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A pediatric case series of acute hemolys
A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin
โœ David J. Gordon; Steven R. Sloan; Jill L.O. de Jong ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 642 KB

Enhanced oxygen delivery to tissues has been shown to improve endurance performance [1]. This has led to widespread abuse of erythropoiesis-stimulating agents (ESA) in elite sport. It is conceivable that athletes have even learned how to continue illicit ESA doping [2]. This possibility has fuelled

Hepatocellular carcinoma after renal tra
Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: A case series
โœ Saeian, Kia ;Franco, Josรฉ ;Komorowski, Richard A. ;Adams, Mark B. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 171 KB

The occurrence of hepatocellular carcinoma (HCC) in renal transplant recipients has typically been associated with hepatitis B or C infection. We encountered two cases of HCC in renal transplant recipients with negative hepatitis B and C markers and no underlying liver pathology, in whom immunosuppr

Rifaximin for the treatment of recurrent
Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series
โœ Guy Neff; Victoria Zacharias; Tiffany E. Kaiser; Amy Gaddis; Nyingi Kemmer ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 211 KB ๐Ÿ‘ 1 views

Previous data have suggested that the nonsystemic antibiotic rifaximin may be effective for the treatment of Clostridium difficile infection (CDI). This single-center retrospective study evaluated the efficacy of rifaximin for the treatment of CDI refractory to standard treatments in patients who ha